B · Normal
[Hong Kong Stock IPO: Weimo Biotechnology (Zhejiang) Co., Ltd.-B submitted to the Hong Kong Stock Exchange] On August 28, Livermore Securities showed that Weimo Biotechnology (Zhejiang) Co., Ltd.-B submitted a listing application to the Hong Kong Stock Exchange, and the exclusive sponsor was CICC.
Comments